COVID-19: NOVEL THERAPY SUGGESTED. Clinicians have discovered that the pathophysiology of COVID-19 and High Altitude Pulmonary Syndrome (HAPS) overlap. This includes pulmonary functions, blood measurements, Histology & Radiographic findings.
Treatment of HAPS has been well studied. Phosphodiesterase inhibitors (Viagra), Acetozolamide, & a calcium channel blocker (Nifedipine) have proved useful to increase tissue oxygenation & to reduce pulmonary artery hypertension & pulmonary edema.
As with the Hydroxchlorthiazide + Zithromax combo, this HAPS therapeutic protocol costs pennies compared to the cost of intensive hospital care; not always successful.
Hopefully, those who have regulatory control of yet-untested therapies for COVID19 will allow the HAPS protocol to be used with patient/family consent; at the same time holding harmless doctors who are willing to foster such therapies of desperation.
@threadreaderapp unroll
